National Drug Strategy
National Drug Strategy

The National Drug Strategy 2010-2015

Executive summary

prev pageTOC |next page

The aim of the National Drug Strategy 2010–2015 is to build safe and healthy communities by minimising alcohol, tobacco and other drug-related health, social and economic harms among individuals, families and communities.

The harms to individuals, families, communities and Australian society as a whole from alcohol, tobacco and other drugs are well known. For example, the cost to Australian society of alcohol, tobacco and other drug misuse 1 in the financial year 2004–05 was estimated at $56.1 billion, including costs to the health and hospitals system, lost workplace productivity, road accidents and crime.

The overarching approach of harm minimisation, which has guided the National Drug Strategy since its inception in 1985, will continue through 2010–2015. This encompasses the three pillars of:

The three pillars apply across all drug types but in different ways, for example, depending on whether the drugs being used are legal or illegal. The approaches in the three pillars will be applied with sensitivity to age and stage of life, disadvantaged populations, and settings of use and intervention.

In the National Drug Strategy 2010– 2015, the three pillars are underpinned by strong commitments to:

Specific objectives have been identified under each pillar as follows:

Demand reduction

Supply reduction

Harm reduction

Part 1 of the National Drug Strategy 2010–2015 provides background and explains the conceptual framework of the strategy.

Part 2 details specific objectives and suggested actions under each pillar.

Part 3 discusses the supporting approaches of workforce, evidence, performance monitoring and governance.

1, Collins, D and Lapsley, H 2008, The Costs of Tobacco, Alcohol and Illicit Drug Abuse to Australian Society in 2004/05, National Drug Strategy Monograph Series No. 64.

prev pageTOC |next page